IL17A and Alzheimer disease: also found that subcutaneous injection of mouse AD-MSCs in mice (1 × 106 cells in 1ml PBS) can especially inhibit the expression of Th17 and its relative pro-inflammatory products including IL-17A, CCL20, and matrix metalloproteinase 12 (MMP12) in AD (50) (Table 1).